The estimated Net Worth of Nimrata Hunt is at least $4.77 Milion dollars as of 1 September 2024. Dr Hunt owns over 343 units of Idexx Laboratories stock worth over $1,556,085 and over the last 5 years he sold IDXX stock worth over $2,034,168. In addition, he makes $1,183,448 as Exec. VP and GM - Point of Care Diagnostics & Worldwide Operations at Idexx Laboratories.
Dr has made over 21 trades of the Idexx Laboratories stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 343 units of IDXX stock worth $168,159 on 1 September 2024.
The largest trade he's ever made was selling 2,776 units of Idexx Laboratories stock on 14 August 2020 worth over $1,047,940. On average, Dr trades about 558 units every 66 days since 2020. As of 1 September 2024 he still owns at least 3,174 units of Idexx Laboratories stock.
You can see the complete history of Dr Hunt stock trades at the bottom of the page.
Dr. Nimrata Khatra Hunt P.E., Ph.D. is the Exec. VP and GM - Point of Care Diagnostics & Worldwide Operations at Idexx Laboratories.
As the Exec. VP and GM - Point of Care Diagnostics & Worldwide Operations of Idexx Laboratories, the total compensation of Dr D at Idexx Laboratories is $1,183,448. There are 9 executives at Idexx Laboratories getting paid more, with Jonathan Ayers having the highest compensation of $8,309,800.
Dr D is 53, he's been the Exec. VP and GM - Point of Care Diagnostics & Worldwide Operations of Idexx Laboratories since . There are 19 older and 4 younger executives at Idexx Laboratories. The oldest executive at Idexx Laboratories, Inc. is M. Anne Szostak, 69, who is the Independent Director.
Nimrata's mailing address filed with the SEC is C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON, CA, 94588.
Over the last 22 years, insiders at Idexx Laboratories have traded over $238,711,289 worth of Idexx Laboratories stock and bought 24,695 units worth $3,109,424 . The most active insiders traders include Stuart Essig, Johnny D Powers a Jonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,641,291. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth $234,685.
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
Idexx Laboratories executives and other stock owners filed with the SEC include: